摘要
Antibodies,as one of the most important components of host adaptive immune system,play an important role in defense of infectious disease,immune surveillance,and autoimmune disease.Due to the development of recombinant antibody technology,antibody therapeutics become the largest and rapidly expanding drug to provide major health benefits to patients,especially for the treatment of cancer patients.Many antibody-based therapeutic strategies have been developed including monoclonal anti-bodies,antibody-drug conjugates,bispecific and trispecific antibodies and pro-antibodies with promising results from both clinical and pre-clinical trials.However,the response rate and side-effect still vary between patients with undefined mechanisms.Here,we summarized the current and future perspectives of antibody-based cancer immunotherapeutic strategies for designing next-generation drugs.
